InnoMed

Shanghai Innomed TECHNOLOGIES Incorporation Limited (hereinafter referred to as “InnoMed”) specializes in the research, development, and production of minimally invasive interventional medical technology products, providing solutions for the treatment of cardiac and systemic vascular diseases. Founded by overseas returnees, the company has received investment from Shanghai state-owned capital and domestic professional medical device investment institutions. Headquartered in the Zhangjiang High-Tech Park within the Shanghai Free Trade Zone, the company occupies over 1,900 square meters of space, featuring GMP-compliant Class 10,000 ultra-clean production workshops and R&D facilities, as well as comprehensive laboratories for product testing and validation. Through years of dedicated research into cardiovascular interventional device methodologies, InnoMed has secured multiple invention patents and utility model patents in areas such as drug-eluting stents, stents for cardiovascular disease treatment, novel balloon dilation catheters, and drug-coating technologies.